ML25002A059
| ML25002A059 | |
| Person / Time | |
|---|---|
| Issue date: | 01/06/2025 |
| From: | Dafna Silberfeld NRC/NMSS/DMSST/MSEB |
| To: | Davis S Teen Cancer America |
| Shared Package | |
| ML25002A060 | List: |
| References | |
| Download: ML25002A059 (1) | |
Text
Simon Davies Teen Cancer America 11845 Olympic Blvd. #775W Los Angeles, CA 90064 simon@teencanceramerica.org
Dear Mr. Davies:
Thank you for your letter dated November 21, 2024 regarding the Patients for Safer Nuclear Medicines concerns and suggestions for NRCs proposed rule and associated guidance on Reporting Nuclear Medicine Injection Extravasations as Medical Events under SECY-24-0067.
The draft proposed rule and associated guidance is currently with the Commission for review and approval.
We will place your letter on the docket. As the draft proposed rule and associated guidance is with the Commission for their review and approval at this time, we will address your concerns on the proposed rule if it is approved by the Commission. Specific information about the rulemaking can be found at https://www.nrc.gov/reading-rm/doc-collections/rulemaking-ruleforum/active/ruledetails.html?id=2180 and at https://www.regulations.gov under Docket ID NRC-2022-0218. We look forward to your continuing participation and engagement in our rulemaking process.
If you have any questions or need additional information, please contact me at Dafna.Silberfeld@nrc.gov or (301) 287-0737 or you can contact the rulemaking project manager, Irene Wu at Irene.Wu@nrc.gov or (301) 415-1951.
Sincerely, Dafna Silberfeld, Deputy Division Director Division of Materials Safety, Security, State, and Tribal Programs Office of Nuclear Material Safety and Safeguards January 6, 2025 Signed by Silberfeld, Dafna on 01/06/25
ML25002A060; Ltr ML25002A059 OFFICE NMSS/MSST/MSEB NMSS/MSST/MSEB OCIO/DIME NAME KTapp CEinberg DSilberfeld DATE Jan 6, 2025 Jan 6, 2025 Jan 6, 2025